Published in Clin Genet on April 01, 2006
Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol (2007) 0.87
Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol (2017) 0.75
Correction for Golomb, "Reply to Blazer et al.: Flawed challenges to 'Acetylcholinesterase inhibitors and Gulf War illnesses',". Proc Natl Acad Sci U S A (2008) 0.75
Reply to Blazer et al.: flawed challenges to "Acetylcholinesterase inhibitors and Gulf War illnesses". Proc Natl Acad Sci U S A (2008) 0.75
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet (2001) 3.59
Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med (1991) 3.45
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke (2000) 2.06
Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta (1998) 1.77
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol (1997) 1.62
Paraoxonase gene polymorphisms and sporadic ALS. Neurology (2006) 1.56
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology (1996) 1.50
Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J Neurochem (1999) 1.47
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol (2005) 1.45
GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD-1) gene. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 1.41
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet (1994) 1.28
Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci (1998) 1.21
Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology (2000) 1.16
Purification and partial characterization of the myelin-associated glycoprotein from adult rat brain. Biochim Biophys Acta (1983) 1.11
Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Ann Neurol (1998) 1.07
Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet (1995) 1.06
Biochemical demonstration of the myelin-associated glycoprotein in the peripheral nervous system. J Neurochem (1981) 1.05
Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther (1999) 1.04
Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport (2000) 1.03
Inoculation of containerized Pinus pinea L. seedlings with seven ectomycorrhizal fungi. Mycorrhiza (2001) 0.96
A two basepair deletion in the SOD 1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet (1994) 0.96
Quantitative detection of Lactarius deliciosus extraradical soil mycelium by real-time PCR and its application in the study of fungal persistence and interspecific competition. J Biotechnol (2006) 0.95
Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. Dement Geriatr Cogn Disord (2009) 0.95
Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis. Exp Neurol (1998) 0.95
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis. Neurochem Res (2006) 0.91
Clinical prediction of airways hyperresponsiveness. Chest (1988) 0.90
Serum albumin level and nosocomial pneumonia in stroke patients. Eur J Neurol (2006) 0.88
Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology (1999) 0.88
Androgen receptor gene polymorphisms in amyotrophic lateral sclerosis. Neuromuscul Disord (1993) 0.87
"Pure" hereditary spastic paraplegias: the story becomes complicated. Neurology (1999) 0.86
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology. Biol Psychiatry (1997) 0.86
Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr (2007) 0.85
Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology (1997) 0.85
Experimental hyperphenylalaninemia: effect on central nervous system myelin subfractions. Exp Neurol (1980) 0.85
Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol (2013) 0.85
Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. AJNR Am J Neuroradiol (2007) 0.85
Progressive multifocal leukoencephalopathy (PML) in a patient with silicosis treated previously with steroids. A report of a case with JC virus infection confirmed immunohistochemically and by electron microscopy. Pol J Pathol (2000) 0.84
Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain. Neuroscience (2000) 0.84
Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathol (1996) 0.84
Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology (1996) 0.83
Interleukin 1beta-511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 0.83
Transient hyperglycemia in ischemic stroke patients. J Neurol Sci (2001) 0.83
A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease. Acta Neurol Scand (2008) 0.83
DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology (2004) 0.83
Gastric electromechanical dysfunction in Parkinson's disease. Funct Neurol (2000) 0.82
Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum. J Mol Neurosci (2012) 0.82
The prognostic significance of microalbuminuria in non-diabetic acute stroke patients. Med Sci Monit (2001) 0.82
Early predictors of 30-day mortality in supratentorial ischemic stroke patients--first episode. Med Sci Monit (2001) 0.81
Clinical implications of the genetics of ALS and other motor neuron diseases. Neurology (2001) 0.81
Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy. Neuroscience (2010) 0.81
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse. Neurology (2010) 0.81
[Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation]. Med Clin (Barc) (1999) 0.81
Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience. Clin Transl Oncol (2009) 0.80
Lack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke. J Neurol Neurosurg Psychiatry (2004) 0.80
[Effect of different storage conditions on the stability of aqueous solutions of chlorhexidine digluconate]. Acta Pol Pharm (1981) 0.80
ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand (2006) 0.80
Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group. Int J Clin Pract Suppl (1999) 0.80
Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide (1998) 0.79